Clinical Trial Update: Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating patiromer for treatment of hyperkalemia in children under 12 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Vifor Pharma, Inc. | Conditions: Hyperkalemia | Phase 2 | Status: RECRUITING